Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)
Status:
Completed
Trial end date:
2016-07-16
Target enrollment:
Participant gender:
Summary
The MOTION study was a prospective, Phase IV study for patients with Pulmonary Arterial
Hypertension (PAH). The study was designed to further explore patient-reported outcomes in
PAH subjects who were not on active treatment and living in the United States. In addition,
the study explored the use of new telemetric technology (Accelerator band) to evaluate if
this technology correlates with improvements in 6 Minute Walking Distance 6MWD in patients
with PAH.